Scientists have devised a triple-stage "cluster bomb" system for delivering the chemotherapy drug cisplatin, via tiny nanoparticles designed to break up when they reach a tumor.
Bio & Medicine
Mar 29, 2016
0
151
The ongoing debate about breast cancer diagnostics has left many women confused—particularly over what age they should get mammograms and who needs treatment. An issue with current methods is that they often identify lumps ...
Analytical Chemistry
Mar 15, 2016
0
81
Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell's protective mechanism against itself—short-circuiting tumor cell metabolism and killing tumor cells.
Bio & Medicine
Feb 18, 2016
0
674
University of Alabama at Birmingham researcher Eugenia Kharlampieva, Ph.D., makes polymer microcapsules meant to carry cancer drugs to the site of a tumor. Working in the UAB Department of Chemistry at the intersection of ...
Bio & Medicine
Feb 15, 2016
0
35
Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through virtual biopsies and then attack the molecular structure of the disease.
Bio & Medicine
May 26, 2015
0
598
MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.
Bio & Medicine
May 8, 2014
1
0
(Phys.org) —Purdue University researchers have developed a way to detect and measure cancer levels in a living cell by using tiny gold particles with tails of synthetic DNA.
Bio & Medicine
Apr 23, 2014
0
0
An aggressive form of breast cancer known as "triple negative" is very difficult to treat: Chemotherapy can shrink such tumors for a while, but in many patients they grow back and gain resistance to the original drugs.
Bio & Medicine
Oct 22, 2013
1
0
(Phys.org) —Herceptin and camptothecin are both powerful anticancer agents with key characteristics that limit their effectiveness in treating cancer. Patients treated with Herceptin, a monoclonal antibody that targets ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org) —The long-standing mystery behind dormant disseminated breast tumor cells and what activates them after years and even decades of latency may have been solved. Researchers with the U.S. Department of Energy (DOE)'s ...
Cell & Microbiology
Jun 3, 2013
0
0
